A multicultural group practicing yoga together in a bright studio

Calibrate vs Wellorithm: GLP-1 Comparison 2026

Calibrate vs Wellorithm: pricing, medication type, clinical support, and which mid-market GLP-1 patient each program fits. Both programs’ prices verified July 2026 or later; each price carries its own date in the table below.

By RangeYourselfUpdated July 25, 20264 min read

Quick answer

Calibrate is a coaching-heavy, brand-name-leaning program; Wellorithm is a more medication-first telehealth experience. Choose Calibrate if you want behavior-change structure; choose Wellorithm if you want straightforward GLP-1 access.

Side-by-side comparison

Feature	Calibrate	Wellorithm
Best for	Coaching-heavy, behavior-change-first program	Mid-market compounded program with structured care
Medication type	Brand-name GLP-1 paired with coaching	Compounded semaglutide and tirzepatide, plus FDA-approved Ozempic®, Wegovy®, Mounjaro®, and Zepbound®
Pricing model	Annual or recurring program fee	Monthly subscription, dose-tier pricing
Semaglutide price	Membership $199/mo (3-month commitment); medication via insurance, copays ≤$25/mo	Not publicly listed (shown after intake)
Tirzepatide price	Membership $199/mo (3-month commitment); medication via insurance, copays ≤$25/mo	Not publicly listed (shown after intake)
Key watchout	Higher overall cost, best when you'll use the coaching	Newer brand, confirm pharmacy partner and refund terms
Price checked	Checked by a person July 3, 2026 · an automated check re-read it September 21, 2026	Checked by a person July 25, 2026

When to choose Calibrate

You want a structured behavior-change program, not just a script
You expect to use coaching, lessons, and tracking actively
You're committed for a year and want a single program fee
You prefer brand-name medication routed through your insurance

Check current Calibrate pricing →

When to choose Wellorithm

You want a structured compounded program with clinical follow-up
You value clear monthly pricing with medication included
You'd like to escalate dose with the same provider
You're comparing newer entrants against larger compounders

Check current Wellorithm pricing →

Full reviews

Frequently asked questions

Is Calibrate cheaper than Wellorithm?

Neither Calibrate nor Wellorithm is uniformly cheaper, both publish dose-banded and formulation-banded pricing that depends on the exact product, dose, and any insurance pathway. Compare the specific tier you'd be on at each before deciding.

Which is better for semaglutide or tirzepatide, Calibrate or Wellorithm?

Both Calibrate and Wellorithm prescribe semaglutide and tirzepatide where appropriate. Choose based on how each program handles your target medication, not just the entry price.

Are Calibrate and Wellorithm compounded or brand-name?

Calibrate offers brand-name glp-1 paired with coaching. Wellorithm offers compounded semaglutide and tirzepatide, plus fda-approved ozempic®, wegovy®, mounjaro®, and zepbound®. If you specifically want brand-name Wegovy or Zepbound, lean toward whichever explicitly supports brand access; if compounded is fine, both can typically meet that need.

Can I switch from Calibrate to Wellorithm?

Yes, switching between Calibrate and Wellorithm is straightforward in most states. You typically finish your current month, complete a new intake with the other provider, and they handle the prescription. Watch for overlap on auto-renewal billing and confirm any dose-tier or formulation differences with the new clinician before your next shipment.

Compare Calibrate and Wellorithm to other programs

Alert me when this gets cheaper

These prices move. Get one email when we publish a verified price drop, the programs on this list included. No spam. Unsubscribe any time.

Related guides

About compounded GLP-1 medicationsCompounded semaglutide and tirzepatide are not FDA-approved finished products. They are prepared by state-licensed 503A pharmacies or 503B outsourcing facilities and are not individually reviewed by the FDA for safety, effectiveness, or quality. Compounders describe these preparations as using the same active ingredient as the approved medicines; the FDA has warned that some compounded products use salt forms, semaglutide sodium or semaglutide acetate, that it considers different active ingredients from the approved drug, and has issued warning letters over marketing that presents a compounded preparation as interchangeable with an approved one. The FDA declared the semaglutide shortage resolved on February 21, 2025 and the tirzepatide shortage resolved in December 2024, so the shortage-era pathway for broad compounding of these drugs has ended. Compounding now proceeds under the ordinary rules: a 503A pharmacy compounding for an individual patient on a prescription, or a 503B outsourcing facility, which compounds in bulk under CGMP and FDA registration rather than per patient. Those rules generally do not cover a product that is “essentially a copy” of an approved drug unless a prescriber documents a change that makes a significant difference for an individual patient. Talk to a clinician about contraindications including personal or family history of medullary thyroid carcinoma or MEN 2. RangeYourself does not provide medical advice, does not guarantee a prescription, and does not guarantee weight-loss results.

RangeYourself is reader-supported. We may earn a commission when you click on certain links, at no extra cost to you. Editorial recommendations are made independently. Pricing reflects publicly listed entry tiers, verified on the dates shown in the table above, and may change. Numbers like Membership $199/mo (3-month commitment); medication via insurance, copays ≤$25/mo and Not publicly listed (shown after intake) are starting tiers, not your guaranteed long-term cost.